As of Beijing time The data is from a third-party organization and is only for reference.
For actual information, please refer to:www.eastmoney.com
Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)
Tel: +1(626)986-9880
Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK
Tel: 0044 7790 816 954
Email: marketing@medicilon.com
Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)
Postcode: 201299
Tel: +86 (21) 5859-1500 (main line)
Fax: +86 (21) 5859-6369
© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888 | Website Map
Business Inquiry
Global:
Email:marketing@medicilon.com
+1(626)986-9880(U.S.)
0044 7790 816 954 (Europe)
China:
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
“Administrative Measures for Drug Registration” (Bureau Order No. 28) for pre-clinical provisions
Article 21 Pre-clinical trial of drugs for the purpose of applying for drug registration, including drug synthesis technology, extraction methods, physical and chemical properties and purity, dosage form selection, prescription screening, preparation technology, inspection methods, quality indicators, stability, pharmacology , Toxicology, Animal pharmacokinetics trial, etc. Traditional Chinese medicine preparations also include research on the source, processing and processing of raw medicinal materials; biological products also include the source of starting raw materials, quality standards, storage conditions, biological characteristics, genetic stability and Immunology research, etc.
Article 22: Pre-clinical drug trials shall implement relevant management regulations, among which safety evaluation research must implement the “Non-clinical Drug trials Quality Management Standards.”
Main pharmacodynamic experiment
General pharmacological research
Acute toxicity test
Long-term toxicity test
Animal pharmacokinetic test
Heritage toxicity test data
Reproductive toxicity test data
Carcinogenic test data
Immunotoxicity and/or immunogenicity studies
Hemolytic and local irritation studies
Experiment on the mutual influence of multiple components in compound preparations on efficacy, toxicity and pharmacokinetics
Dependency experiment
Different products are treated differently
Emphasize the quality control of the whole process
Determine the content by activity
Biological drugs are usually stored at 2~8℃
General pharmacology is extensive pharmacological research beyond the main pharmacodynamic effects, including secondary pharmacodynamics and safety pharmacology.
1. Nervous system: quantitatively and qualitatively evaluate the motor function, behavior change, coordination function, sensory/motor reflex and body temperature changes of animals after administration.
2. Cardiovascular system: measure changes in blood pressure, electrocardiogram and heart rate before and after administration
3. Respiratory system: Measure changes in respiratory frequency and respiratory depth before and after administration.
Single dose toxicity test (rodent and non-rodent)
Repeated administration toxicity test (rodent and non-rodent)
Safety pharmacology test: central nervous system research, cardiovascular system (telemetry and non-telemetry technology for dogs and monkeys), respiratory system
Genetic toxicity test
Reproductive toxicity test [fertility and early embryo development toxicity test (reproductive stage I), embryo-fetal development toxicity test (reproductive stage II)]
Immunogenicity test
Toxicokinetics
Local toxicity test (hemolysis, allergy, irritation test)
Pre-clinical laboratory animal selection: According to regulatory requirements, guiding principles and recommendations, and practical experience, choose easy-to-obtain, easy-to-feed, easy-to-operate and manage, eating habits close to humans or eating half of the food can survive healthy.
Shanghai Medicilon is a professional pre-clinical CRO company specializing in outsourcing services for pharmaceutical R&D.
Phone: 86-021-58591500
Email: marketing@meidicilon.com